Delivery Order SPE2DB22D1106-SPE2DB24FDSH1

Award Date 12/26/23
Potential Completion Date 12/27/23
Potential Value $22K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $3,983.95. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This federal contract award is for the delivery of pharmaceutical products, primarily focused on the drug Jardiance 25 mg tablet, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,646.91 and an ultimate completion date of November 15, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $63,747.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 16, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg Tablets, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $7,747.73. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of July 1, 2024. The contract is not designated as a Set-Aside....
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $11,279.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $4,061.41, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 12, 2024, with a completion date of March 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Jardiance 25 mg tablets (30s) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,035.97 delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC enables the DLA to procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The $19,736.17 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 28, 2023 and was awarded on September 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Jardiance 10 mg tablets to fulfill pharmaceutical needs. The $5,786.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Jardiance 10 mg tablets (90 count) to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $13,524.42 and is a firm fixed-price delivery order with a completion date of February 19, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDSH1
    Delivery Order

This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $21,800.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. The contract is expected to be completed by December 27, 2023.

Generated 5/13/25, 9:42 AM